BlackRock Japan’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

BlackRock Japan’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$17K	Sell	336 -34	-9%	-$1.79K	﹤0.01%	1159
2016 Q3	$19K	Sell	370 -58	-14%	-$2.77K	﹤0.01%	1134
2016 Q2	$18K	Buy	428 +271	+173%	+$11.8K	﹤0.01%	1185
2016 Q1	$6K	Sell	157 -504	-76%	-$17.3K	﹤0.01%	1349
2015 Q4	$27K	Sell	661 -402	-38%	-$13.5K	﹤0.01%	1124
2015 Q3	$16K	Sell	1,063 -73	-6%	-$1.57K	﹤0.01%	1124
2015 Q2	$28K	Sell	1,136 -934	-45%	-$20.8K	﹤0.01%	1149
2015 Q1	$47K	Buy	2,070 +2	+0.1%	+$50	﹤0.01%	1075
2014 Q4	$56K	Buy	+2,068	New	+$35.6K	﹤0.01%	1079

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's FPRX Position: Q4 2016 in Review

BlackRock Japan reduced its Five Prime Therapeutics, Inc. (FPRX) stake by 9.2% in Q4 2016, selling an estimated $1.79K and leaving 336 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

BlackRock Japan first reported a position in FPRX in Q4 2014 and has held it in 9 quarters since. The position peaked at $56K in Q4 2014. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

BlackRock Japan held 336 shares of Five Prime Therapeutics, Inc. worth $17K as of Q4 2016.
BlackRock Japan sold 34 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $1.79K.
Five Prime Therapeutics, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1159 holding.
BlackRock Japan first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Japan's Five Prime Therapeutics, Inc. position peaked at $56K in Q4 2014.
172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.